Tissue abnormalities and damage

  • Monitoring organ damage and tissue abnormalities in real time.Isolation of organs and cells for IHC.


  • Acute toxicity testing
  • Sub-chronic and chronic toxicity studies

Drug screening

  • Blood levels of drug metabolites using gene expression profiling and mass spectrometry
    Sub-chronic and chronic toxicity studies
  • High throughput drug screening and metabolic clearance


  • Real time in vivo vascularization

Cell-based assays

  • Cytokine screening and flow cytometry
  • Isolation and maintaining inflammatory cells